A Study in Male and Female Adolescent Participants With Severe Uncontrolled Asthma Starting Treatment With Dupilumab Injection (Dupixent®)

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1. 1This study has already been completed — does that mean the results are available, and if so, what did the data show about how dupilumab worked in adolescents with severe uncontrolled asthma like mine?
2. 2Since this study mainly collected background information like medical history, demographics, and previous treatments rather than testing a new drug head-to-head, would its findings actually change how you'd approach my treatment, or is there stronger evidence from other dupilumab trials I should know about?
3. 3The study focused specifically on adolescents with severe uncontrolled asthma — does my history of previous asthma treatments and how well my asthma is currently controlled match the kind of patients who were enrolled, and does that affect whether dupilumab might be worth considering for me?
4. 4Before thinking about dupilumab, are there standard asthma treatments I haven't tried yet that should come first, or does my level of severity put me at a point where a biologic like dupilumab is already the right conversation to have?
5. 5Since this was a real-world observational study rather than a controlled clinical trial, how confident are you in what we know about dupilumab's safety and benefit specifically for someone my age with my asthma profile?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.